Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco Dorsey Wright Momentum ETF
PDP
|
+$591M |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$240M |
| 3 |
Boston Scientific
BSX
|
+$194M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$193M |
| 5 |
Clarivate
CLVT
|
+$158M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.25B |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$809M |
| 3 |
Willis Towers Watson
WTW
|
+$664M |
| 4 |
AstraZeneca
AZN
|
+$658M |
| 5 |
Microsoft
MSFT
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.19% |
| 2 | Financials | 6.48% |
| 3 | Consumer Discretionary | 5.4% |
| 4 | Healthcare | 5.05% |
| 5 | Communication Services | 4.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TPTX
2401
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $2.32M | ﹤0.01% |
34,889
-25,972
| -43% | -$1.85M |
|
2402
CALL
Bilibili
BILI
$8B
| $2.32M | ﹤0.01% |
+35,000
| New | +$3M |
|
2403
Brookfield Infrastructure Partners
BIP
$19.1B
| $2.32M | ﹤0.01% |
61,935
-9,122
| -13% | -$339K |
|
|
GBT
2404
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $2.31M | ﹤0.01% |
90,825
-23,762
| -21% | -$698K |
|
|
GPX
2405
DELISTED
GP Strategies Corp.
GPX
| $2.31M | ﹤0.01% |
111,485
+110,886
| +18,512% | +$2.2M |
|
2406
Lincoln Electric
LECO
$14.5B
| $2.31M | ﹤0.01% |
17,899
-2,551
| -12% | -$347K |
|
2407
Green Dot
GDOT
$744M
| $2.3M | ﹤0.01% |
45,700
-1,708
| -4% | -$82.2K |
|
|
SWI
2408
DELISTED
SolarWinds Corporation Common Stock
SWI
| $2.29M | ﹤0.01% |
137,134
+3,787
| +3% | +$70K |
|
|
CXP
2409
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
| $2.29M | ﹤0.01% |
120,516
-33,404
| -22% | -$581K |
|
2410
Domo
DOMO
$178M
| $2.29M | ﹤0.01% |
27,151
-4,711
| -15% | -$403K |
|
|
VRNT
2411
DELISTED
Verint Systems
VRNT
| $2.29M | ﹤0.01% |
51,161
-14,708
| -22% | -$640K |
|
2412
Vicor
VICR
$9.46B
| $2.28M | ﹤0.01% |
17,016
+5,169
| +44% | +$618K |
|
|
VISN
2413
PUT
Vistance Networks Inc
VISN
$2.63B
| $2.28M | ﹤0.01% |
167,600
-100,000
| -37% | -$1.72M |
|
|
MYOV
2414
DELISTED
Myovant Sciences Ltd.
MYOV
| $2.28M | ﹤0.01% |
101,457
-75,034
| -43% | -$1.65M |
|
2415
California Water Service
CWT
$3.08B
| $2.27M | ﹤0.01% |
38,569
+5,520
| +17% | +$340K |
|
2416
Playtika
PLTK
$1.57B
| $2.27M | ﹤0.01% |
82,214
+18
| +0% | +$448 |
|
|
LONA
2417
LeonaBio Inc
LONA
$66.3M
| $2.27M | ﹤0.01% |
24,206
+17,630
| +268% | +$1.79M |
|
2418
CALL
Rexford Industrial Realty
REXR
$8.45B
| $2.27M | ﹤0.01% |
+40,000
| New | +$2.41M |
|
|
TSPQ.U
2419
DELISTED
TCW Special Purpose Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant
TSPQ.U
| $2.27M | ﹤0.01% |
230,239
| – | – |
|
2420
CALL
Colgate-Palmolive
CL
$74.4B
| $2.27M | ﹤0.01% |
30,000
| – | – |
|
2421
Murphy USA
MUSA
$11B
| $2.27M | ﹤0.01% |
13,554
-115,300
| -89% | -$17.4M |
|
|
KAMN
2422
DELISTED
Kaman Corp
KAMN
| $2.26M | ﹤0.01% |
63,476
-5,187
| -8% | -$214K |
|
2423
Envista
NVST
$4.49B
| $2.26M | ﹤0.01% |
54,065
-12,529
| -19% | -$528K |
|
|
PPBI
2424
DELISTED
Pacific Premier Bancorp
PPBI
| $2.26M | ﹤0.01% |
54,467
-41,471
| -43% | -$1.63M |
|
2425
Semtech
SMTC
$10.9B
| $2.26M | ﹤0.01% |
28,954
+4,437
| +18% | +$304K |
|
Similar funds
Citigroup's Q3 2021 Portfolio in Review
As of Q3 2021, Citigroup held 6,611 positions worth $169B, up 1.9% from $166B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Citigroup deployed $5.8B of net new capital in Q3 2021, opening 423 new positions and adding to 2,034 existing holdings. Its largest new stake was Hennessy Capital Investment Corp. VI Unit: 9,095,000 shares worth $90.5M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.25B trimmed.
- Citigroup's largest Q3 2021 buy was Hennessy Capital Investment Corp. VI Unit: 9,095,000 shares worth $90.5M.
- Citigroup added most to Invesco Dorsey Wright Momentum ETF in Q3 2021, an estimated $591M increase.
- Citigroup's biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.25B.
- Citigroup fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $809M.
- Citigroup's ten largest holdings make up 25% of its $169B portfolio in Q3 2021.
- Citigroup opened 423 new positions and closed 793 in Q3 2021.
- Citigroup's portfolio value rose 1.9% quarter-over-quarter to $169B.
Based on Citigroup's 13F filing for Q3 2021, filed 10 Nov 2021.